BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 15504095)

  • 1. [Managing methotrexate toxicity: a case report].
    Fernández Megía MJ; Alós Almiñana M; Terol Castera MJ
    Farm Hosp; 2004; 28(5):371-4. PubMed ID: 15504095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose methotrexate-associated acute renal failure may be an avoidable complication.
    Fong CM; Lee AC
    Pediatr Hematol Oncol; 2006; 23(1):51-7. PubMed ID: 16326413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyper-alkalinization without hyper-hydration for the prevention of high-dose methotrexate acute nephrotoxicity in patients with osteosarcoma.
    Mir O; Ropert S; Babinet A; Alexandre J; Larousserie F; Durand JP; Enkaoua E; Anract P; Goldwasser F
    Cancer Chemother Pharmacol; 2010 Nov; 66(6):1059-63. PubMed ID: 20155268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of plasma exchange in methotrexate removal in a patient with osteosarcoma and acute renal insufficiency.
    Cecyn KZ; Lee J; Oguro T; Petrilli AS; Bordin JO
    Am J Hematol; 2003 Mar; 72(3):209-11. PubMed ID: 12605394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management recommendations in patients with methotrexate intoxication].
    Schellens JH; Beijnen JH
    Ned Tijdschr Geneeskd; 2007 Feb; 151(6):337-41. PubMed ID: 17352296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymidine rescue: an antidote for pemetrexed-related toxicity in the setting of acute renal failure.
    Castro M
    J Clin Oncol; 2003 Nov; 21(21):4066. PubMed ID: 14581433
    [No Abstract]   [Full Text] [Related]  

  • 7. High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma.
    Widemann BC; Balis FM; Kempf-Bielack B; Bielack S; Pratt CB; Ferrari S; Bacci G; Craft AW; Adamson PC
    Cancer; 2004 May; 100(10):2222-32. PubMed ID: 15139068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe acute renal failure following high-dose methotrexate therapy in adults with haematological malignancies: a significant number result from unrecognized co-administration of several drugs.
    de Miguel D; García-Suárez J; Martín Y; Gil-Fernández JJ; Burgaleta C
    Nephrol Dial Transplant; 2008 Dec; 23(12):3762-6. PubMed ID: 18779628
    [No Abstract]   [Full Text] [Related]  

  • 9. High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance.
    Joannon P; Oviedo I; Campbell M; Tordecilla J
    Pediatr Blood Cancer; 2004 Jul; 43(1):17-22. PubMed ID: 15170885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction.
    Widemann BC; Balis FM; Murphy RF; Sorensen JM; Montello MJ; O'Brien M; Adamson PC
    J Clin Oncol; 1997 May; 15(5):2125-34. PubMed ID: 9164227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adsorption of methotrexate and calcium leucovorin onto cholestyramine in vitro.
    Merino-Sanjuán M; Carrera A; Monte E; Jiménez-Torres NV
    Int J Pharm; 2004 Jul; 278(2):283-91. PubMed ID: 15196633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal failure after high-dose methotrexate in a child homozygous for MTHFR C677T polymorphism.
    Turello R; Rentsch K; Di Paolo E; Popovic MB
    Pediatr Blood Cancer; 2008 Jan; 50(1):154-6. PubMed ID: 17387702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful rescue by oral cholestyramine of a patient with methotrexate nephrotoxicity: nonrenal excretion of serum methotrexate.
    Shinozaki T; Watanabe H; Tomidokoro R; Yamamoto K; Horiuchi R; Takagishi K
    Med Pediatr Oncol; 2000 Mar; 34(3):226-8. PubMed ID: 10696135
    [No Abstract]   [Full Text] [Related]  

  • 14. Antineoplastic agents: high-dose methotrexate and citrovorum factor rescue.
    Sadée W
    Ther Drug Monit; 1980; 2(2):177-85. PubMed ID: 6762711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Carboxypeptidase-G2 administration after high-dose methotrexate. Treatment and drug interactions].
    Cózar Olmo JA; Martínez Colmenero C; Peláez Pleguezuelos I; Leiva Gea I; López García AB; de la Cruz Moreno J
    An Pediatr (Barc); 2009 Sep; 71(3):230-4. PubMed ID: 19617010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic drug monitoring of methotrexate after its administration in high-dose protocols].
    Le Guellec C; Blasco H; Benz I; Hulin A;
    Therapie; 2010; 65(3):163-9. PubMed ID: 20699066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful rescue with leucovorin and thymidine in a patient with high-dose methotrexate induced acute renal failure.
    van den Bongard HJ; Mathĵt RA; Boogerd W; Schornagel JH; Soesan M; Schellens JH; Beijnen JH
    Cancer Chemother Pharmacol; 2001 Jun; 47(6):537-40. PubMed ID: 11459208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Memorial Sloan Kettering Cancer Center experience with outpatient administration of high dose methotrexate with leucovorin rescue.
    Zelcer S; Kellick M; Wexler LH; Gorlick R; Meyers PA
    Pediatr Blood Cancer; 2008 Jun; 50(6):1176-80. PubMed ID: 18266225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early recognition of renal toxicity of high-dose methotrexate therapy: a case report.
    Nowicki TS; Bjornard K; Kudlowitz D; Sandoval C; Jayabose S
    J Pediatr Hematol Oncol; 2008 Dec; 30(12):950-2. PubMed ID: 19131789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose methotrexate with folinic acid rescue.
    Bender JF; Grove WR; Fortner CL
    Am J Hosp Pharm; 1977 Sep; 34(9):961-5. PubMed ID: 333910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.